favipiravir

Research
thumbs up

Stanford researchers test oral COVID-19 treatment for mild cases

Samantha Nichols
  •  
Aug. 21, 2020
Research
The COVID-19 pandemic has infected an estimated 11.6 million people globally. Our roundup this week highlights a new clinical trial underway for favipiravir, an oral medication with the potential to treat coronavirus symptoms. (Photo: Pixabay)

Research Roundup: Oral medication for COVID-19, air pollution increases infant mortality, AI predicts depression

Derek Chen
  •  
July 7, 2020
The Stanford Daily

Login or create an account